NCT07075341

Brief Summary

The Healthy Living BEYOND Weight Study is an observational research study of participants living with overweight and obesity. The principal objectives for this project will be to answer fundamental unanswered questions regarding patient experiences and outcomes related to overweight and obesity, and to assess the real-world effectiveness of different weight management strategies, within contemporary and diverse populations. To accomplish this, the Study Team for this project will leverage their expertise in the science of obesity and cardiometabolic health; epidemiology, cohort and registry studies; implementation science; cardiovascular prevention and management; and disparities and community-based research to lead the development of an innovative cohort of people living with overweight or obesity with two key components:

  1. 1.patient-report data elements, obtained through surveys;
  2. 2.linkage to EHR records providing data regarding clinical encounters.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000,000

participants targeted

Target at P75+ for all trials

Timeline
421mo left

Started Jun 2025

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress2%
Jun 2025Dec 2060

First Submitted

Initial submission to the registry

June 3, 2025

Completed
27 days until next milestone

Study Start

First participant enrolled

June 30, 2025

Completed
20 days until next milestone

First Posted

Study publicly available on registry

July 20, 2025

Completed
35.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2060

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2060

Last Updated

August 6, 2025

Status Verified

August 1, 2025

Enrollment Period

35.4 years

First QC Date

June 3, 2025

Last Update Submit

August 1, 2025

Conditions

Keywords

overweightobesityweight managementBMIcardiovascular diseaseCardiovascular-Kidney MetabolicCVDCKMGLP-1 RAglucagon-like peptide-1GLP-1GLP-1 receptor agonistsbariatric

Outcome Measures

Primary Outcomes (4)

  • Answer fundamental unanswered questions regarding patient experiences and outcomes related to overweight and obesity.

    From enrollment to at least 10 years post enrollment, continuous follow up

  • Evaluate the real-world effectiveness of different weight management strategies, within contemporary and diverse patient populations.

    From enrollment to at least 10 years post enrollment, continuous follow up

  • Create a community of volunteers interested in advancing research on the conditions of overweight/obesity and related weight management strategies.

    From enrollment to at least 10 years post enrollment

  • To provide an enduring resource of value to individuals living with overweight and obesity.

    From enrollment to at least 10 years post enrollment

Study Arms (1)

Direct-to-Participant Group

Observational

Other: None - Observational study

Interventions

None - Observational study

Direct-to-Participant Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Individuals currently residing in the United States

You may qualify if:

  • BMI at the time of enrollment of 25 kg/m2 or greater or other elevated adiposity measures (e.g., waist circumference of greater than 102cm (40 in) in men or 88cm (35 in) in women) OR adults with a BMI less than 25 due to previous or current weight management treatment (lifestyle, pharmacological or surgical).

You may not qualify if:

  • Incarcerated at the time of enrollment
  • Self-reported pregnancy at the time of enrollment. However, individuals who become pregnant after enrollment will be welcomed to continue to participate, given that the critical life period of pregnancy often has a significant impact on subsequent weight trajectories.
  • Terminal illness or end-stage disease with a life expectancy of less than 6-months
  • Employed by the American Heart Association or working on the Healthy Living BEYOND Weight Study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

American Heart Association

Dallas, Texas, 75231, United States

RECRUITING

Related Links

MeSH Terms

Conditions

OverweightObesityCardiovascular Diseases

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 3, 2025

First Posted

July 20, 2025

Study Start

June 30, 2025

Primary Completion (Estimated)

December 1, 2060

Study Completion (Estimated)

December 1, 2060

Last Updated

August 6, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will share

Data from surveys will be combined with data from the EHR. Data that are stored in the integrated study database will use unique participant identification numbers, with data otherwise de-identified. We will utilize multiple data quality control processes to ensure the accuracy and reliability of study data. The integrated database will be maintained by the AHA or another service provider that is approved in advance by the IRB. Data collected as part of the Healthy Living BEYOND Weight Study will be used for research purposes only and will not be used for diagnosis or disease management.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
July 2026 - ending 5 years after study close
Access Criteria
Study participant de-identified data will be accessible by the AHA and organizations doing work on their behalf such as qualified researchers, academic institutions, patient-advocacy groups, pharmaceutical, medical device companies, Evidation Health, Inc., and more. Study participant de-identified data may be used for the following: * Determination of clinical Study eligibility and subsequent screening, recruitment and enrollment. If a participant chooses to join a clinical Study for which they are eligible, they may be asked to sign an additional Study-specific consent form. * Use for research across a variety of disciplines and for use in scientific publications, interventional and/or product development. Data will be stored in a HIPAA-compliant, secure electronic platform with access limited to authorized study personnel and authorized researchers with executed data use agreements.
More information

Locations